Sarita, Reexhelyn .
HRN: 00-38-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2024
CEFUROXIME 1.5GM (VIAL)
07/09/2024
07/11/2024
IV
1.5g
Q8hrs
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes